NEXT Oncology -Dallas — Irving, Texas

NEXT Oncology -Dallas is a clinical research site located in Irving, Texas, United States 75039.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

NEXT Oncology -Dallas has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Solid Tumor.

Sponsors: Aprea Therapeutics.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NEXT Oncology -Dallas?

NEXT Oncology -Dallas has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NEXT Oncology -Dallas conducted?

NEXT Oncology -Dallas has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Solid Tumor.

Is NEXT Oncology -Dallas accredited by Crixeo Health?

NEXT Oncology -Dallas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NEXT Oncology -Dallas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.